Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 3
1948 6
1949 4
1950 4
1951 1
1952 3
1953 10
1954 6
1955 9
1956 12
1957 9
1958 1
1959 16
1960 17
1961 21
1962 35
1963 44
1964 80
1965 86
1966 36
1967 38
1968 83
1969 85
1970 102
1971 131
1972 141
1973 100
1974 126
1975 115
1976 73
1977 71
1978 71
1979 66
1980 107
1981 81
1982 81
1983 81
1984 67
1985 49
1986 77
1987 73
1988 123
1989 139
1990 165
1991 183
1992 207
1993 217
1994 232
1995 194
1996 181
1997 230
1998 184
1999 275
2000 421
2001 477
2002 540
2003 677
2004 768
2005 905
2006 1041
2007 1139
2008 1322
2009 1323
2010 1546
2011 1686
2012 1715
2013 1634
2014 1633
2015 1261
2016 1064
2017 1083
2018 892
2019 921
2020 887
2021 882
2022 795
2023 406
2024 246

Text availability

Article attribute

Article type

Publication date

Search Results

26,901 results

Results by year

Filters applied: . Clear all
Page 1
A Brief Review of Gepants.
Li D, Abreu J, Tepper SJ. Li D, et al. Curr Pain Headache Rep. 2023 Sep;27(9):479-488. doi: 10.1007/s11916-023-01142-1. Epub 2023 Aug 2. Curr Pain Headache Rep. 2023. PMID: 37531032 Review.
Futibatinib.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2023 Apr 8;80(8):470-472. doi: 10.1093/ajhp/zxad017. Am J Health Syst Pharm. 2023. PMID: 36807400 No abstract available.
Capivasertib: First Approval.
Shirley M. Shirley M. Drugs. 2024 Mar;84(3):337-346. doi: 10.1007/s40265-024-01998-6. Drugs. 2024. PMID: 38388873 Review.
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors.
Vieito M, Moreno V, Spreafico A, Brana I, Wang JS, Preis M, Hernández T, Genta S, Hansen AR, Doger B, Galvao V, Lenox L, Brown RJ, Kalota A, Mehta J, Pastore F, Patel B, Mistry P, Gu J, Lauring J, Patel MR. Vieito M, et al. Clin Cancer Res. 2023 Sep 15;29(18):3592-3602. doi: 10.1158/1078-0432.CCR-23-0092. Clin Cancer Res. 2023. PMID: 37491846 Clinical Trial.
26,901 results
You have reached the last available page of results. Please see the User Guide for more information.